Skip to main content
. 2021 Mar 30;26(1):265–278. doi: 10.1007/s11030-021-10209-3

Table 2.

Pharmacokinetic and drug-likeness properties

Compound Violation of LoF GI absorption TPSA BBB permeation Veber’s rule violation Synthetic accessibility
A1 0 High 128.84 No 0 5.63
A2 0 High 90.90 No 0 4.24
A3 0 High 100.13 No 0 4.43
A4 0 High 111.13 No 0 3.14
A5 0 High 96.22 No 0 4.77